News Bausch + Lomb Corporation Toronto S.E.

Equities

BLCO

CA0717051076

Market Closed - Toronto S.E. Other stock markets 20:20:16 24/05/2024 BST			5-day change	1st Jan Change
20.61 ^CAD	+1.63%		+3.46%	-9.09%

05-06	Bausch + Lomb Shares Rise After Morgan Stanley Upgrade	MT
05-06	Morgan Stanley Upgrades Bausch + Lomb to Overweight From Equalweight, Raises Price Target to $18 From $16	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bausch Health Companies - Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024	05-20	AQ
Bausch Health Announces 2024 Annual Meeting of Shareholder Results	05-16	AQ
Bausch + Lomb : 2023 Report	05-16	PU
Bausch + Lomb Shares Rise After Morgan Stanley Upgrade	05-06	MT
Morgan Stanley Upgrades Bausch + Lomb to Overweight From Equalweight, Raises Price Target to $18 From $16	05-06	MT
Bausch Health Announces First Quarter 2024 Results	05-03	AQ
RBC Capital Reviews Bausch + Lomb's Q1 Results	05-02	MT
Deutsche Bank Adjusts Bausch + Lomb Price Target to $14 From $18, Maintains Hold Rating	05-02	MT
Needham Says Bausch + Lomb's Q1 Showed a "Strong Start" to The Year	05-01	MT
Bausch + Lomb Q1 Loss Widens, Revenue Increases	05-01	MT
Transcript : Bausch + Lomb Corporation, Q1 2024 Earnings Call, May 01, 2024	05-01
Bausch + Lomb Q1 Net Loss Widens, But Revenue Higher; Raises 2024 Revenue Growth Guidance	05-01	MT
Bausch + Lomb: Q1 Earnings Snapshot	05-01	AQ
Bausch + Lomb Brief: Raising Full-Year 2024 Constant Currency Revenue Growth Guidance	05-01	MT
Bausch + Lomb Brief: Q1 Adjusted EBITDA (non-GAAP) of US$180 Million	05-01	MT
Bausch + Lomb Brief: Q1 Revenue of US$1.099 Billion; GAAP Net Loss Attributable of $167 Million	05-01	MT
Bausch + Lomb Announces First-Quarter 2024 Results	05-01	BU
Bausch + Lomb Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	05-01	CI
Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting	04-29	BU
Bausch + Lomb Says Study Shows Improvements in Dry Eyes With Nutritional Supplement	04-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Bausch + Lomb Corporation Toronto S.E.

Equities

BLCO

CA0717051076

Summary

Filters